Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
1994 1
1997 1
1999 1
2002 2
2005 1
2008 2
2009 3
2010 3
2011 2
2012 3
2013 2
2014 2
2015 2
2016 5
2017 2
2018 2
2019 3
2020 2
2021 3
2022 3
2023 3
2024 0

Text availability

Article attribute

Article type

Publication date

Search Results

45 results

Results by year

Filters applied: . Clear all
Page 1
Fostamatinib for the treatment of adult persistent and chronic immune thrombocytopenia: Results of two phase 3, randomized, placebo-controlled trials.
Bussel J, Arnold DM, Grossbard E, Mayer J, Treliński J, Homenda W, Hellmann A, Windyga J, Sivcheva L, Khalafallah AA, Zaja F, Cooper N, Markovtsov V, Zayed H, Duliege AM. Bussel J, et al. Among authors: trelinski j. Am J Hematol. 2018 Jul;93(7):921-930. doi: 10.1002/ajh.25125. Epub 2018 May 15. Am J Hematol. 2018. PMID: 29696684 Free PMC article. Clinical Trial.
Efficacy and safety of the neonatal Fc receptor inhibitor efgartigimod in adults with primary immune thrombocytopenia (ADVANCE IV): a multicentre, randomised, placebo-controlled, phase 3 trial.
Broome CM, McDonald V, Miyakawa Y, Carpenedo M, Kuter DJ, Al-Samkari H, Bussel JB, Godar M, Ayguasanosa J, De Beuf K, Rodeghiero F, Michel M, Newland A; ADVANCE Investigator Study Group. Broome CM, et al. Lancet. 2023 Nov 4;402(10413):1648-1659. doi: 10.1016/S0140-6736(23)01460-5. Epub 2023 Sep 28. Lancet. 2023. PMID: 37778358 Clinical Trial.
Phase 2 multiple-dose study of an FcRn inhibitor, rozanolixizumab, in patients with primary immune thrombocytopenia.
Robak T, Kaźmierczak M, Jarque I, Musteata V, Treliński J, Cooper N, Kiessling P, Massow U, Woltering F, Snipes R, Ke J, Langdon G, Bussel JB, Jolles S. Robak T, et al. Among authors: trelinski j. Blood Adv. 2020 Sep 8;4(17):4136-4146. doi: 10.1182/bloodadvances.2020002003. Blood Adv. 2020. PMID: 32886753 Free PMC article. Clinical Trial.
Antithrombin Deficiency Is Associated with Prothrombotic Plasma Fibrin Clot Phenotype.
Natorska J, Corral J, de la Morena-Barrio ME, Bravo-Pérez C, Bagoly Z, Bereczky Z, Treliński J, Witkowski M, Klajmon A, Undas A, Ząbczyk M. Natorska J, et al. Among authors: trelinski j. Thromb Haemost. 2023 Sep;123(9):880-891. doi: 10.1055/s-0043-1768712. Epub 2023 May 18. Thromb Haemost. 2023. PMID: 37201530 Free PMC article.
Momelotinib reduces transfusion requirements in patients with myelofibrosis.
Mesa R, Oh ST, Gerds AT, Gupta V, Catalano J, Cervantes F, Devos T, Hus M, Kiladjian JJ, Lech-Maranda E, McLornan D, Palmer J, Platzbecker U, Treliński J, Shimoda K, Donahue R, D'Hollander K, Kowalski M, Verstovsek S. Mesa R, et al. Among authors: trelinski j. Leuk Lymphoma. 2022 Jul;63(7):1718-1722. doi: 10.1080/10428194.2022.2043304. Epub 2022 Mar 7. Leuk Lymphoma. 2022. PMID: 35255234 No abstract available.
Functional, biochemical, molecular and clinical characterization of antithrombin c.1157T>C (p.Ile386Thr), a recurrent Polish variant with a founder effect.
Weronska A, De la Morena-Barrio B, Goldman-Mazur S, De la Morena-Barrio ME, Padilla J, Miñano A, Garrido P, Treliński J, Potaczek DP, Szczepanek A, Undas A, Corral J, Wypasek E. Weronska A, et al. Among authors: trelinski j. Haematologica. 2023 Oct 1;108(10):2803-2807. doi: 10.3324/haematol.2022.282459. Haematologica. 2023. PMID: 37021543 Free PMC article. No abstract available.
Determination and interpretation of MTHFR gene mutations in gynecology and internal medicine.
Undas A, Chojnowski K, Klukowska A, Łętowska M, Mital A, Młynarski W, Musiał J, Podolak-Dawidziak M, Sąsiadek M, Treliński J, Urasiński T, Windyga J, Zdziarska J, Zawilska K. Undas A, et al. Among authors: trelinski j. Pol Arch Intern Med. 2019 Oct 30;129(10):728-732. doi: 10.20452/pamw.15039. Epub 2019 Oct 30. Pol Arch Intern Med. 2019. PMID: 31670725 Free article. Review. No abstract available.
[Anagrelide--new antiplatelet drug].
Robak T, Treliński J, Hołub A. Robak T, et al. Among authors: trelinski j. Acta Haematol Pol. 1994;25(4):309-15. Acta Haematol Pol. 1994. PMID: 7847031 Review. Polish.
Acquired haemophilia A in a Jehovah's Witness.
Chojnowski K, Robak M, Nowak W, Treliński J. Chojnowski K, et al. Among authors: trelinski j. Haemophilia. 2016 Sep;22(5):e449-51. doi: 10.1111/hae.12992. Epub 2016 Jun 24. Haemophilia. 2016. PMID: 27340946 No abstract available.
45 results